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Edited by Horst FeldmannAbstract Extracellular ATP regulates many hepatic functions
by stimulating purinergic receptors. Only the G protein-coupled
P2Y receptors have been studied in hepatocytes. We investigated
the functional expression of P2X receptors, the ATP-gated chan-
nels in rat hepatocytes. P2X4 and P2X7 transcripts and proteins
were detected by RT-PCR and by both Western blotting and
immunocytochemistry. High concentrations of ATP, and 2 0-
and 3 0-O-(4-benzoylbenzoyl)-ATP the preferring agonist of
P2X7, induced membrane blebbing and signiﬁcant uptake of 4-
[(3-methyl-2(3H)-benzoxazolylidene)methyl]-1-[3-(triethylam-
monio)propyl]diiodide, both of which were inhibited by oxidised
ATP, a blocker of P2X receptors. These results provide evidence
that P2X4 and P2X7 receptors are expressed and functional on
rat hepatocytes, possibly playing an important role in the puri-
nergic signaling complex in these cells.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Extracellular nucleotides are emerging as ubiquitous media-
tors of cell–cell communication in most tissues [1], and as po-
tent stimuli for the release of bioactive factors from many
diﬀerent cell types [2]. Extracellular ATP is present in bile
and hepatic venous blood in the liver, albeit at low concentra-
tions. It is also present in the supernatant of cultured cells of
hepatic origin (see [3] for review). Moreover ATP may also
be released in response to various stimuli, such as mechanical
stimulation, increase in cell volume [4,5]. Once in the pericellu-
lar environment, ATP modulates many important hepatic
functions, such as gluconeogenesis, protein synthesis and bile
secretion [6,7], via speciﬁc P2 receptors. There are several types
of P2 receptors: ligand-gated cationic channels or P2X recep-
tors, and G protein-coupled P2Y receptors. In the liver, P2Y
receptors are expressed by all cell types [1,6,8,9] and are wellAbbreviations: YO-PRO-1, 4-[(3-methyl-2(3H)-benzoxazolylid-
ene)methyl]-1-[3-(triethylammonio)propyl]diiodide; BzATP, 20- and
3 0-O-(4-benzoylbenzoyl)-ATP; oATP, oxidised ATP
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doi:10.1016/j.febslet.2007.06.016characterized [10]. However, it has been suggested that activa-
tion of a P2Z receptor, now known as P2X7 [11], is involved in
ATP-induced cytotoxicity in hepatocytes [12]. Furthermore,
ATP has been shown to activate a cation-selective current in
isolated guinea pig hepatocytes even in the absence of a P2Y
response [13]. The aim of the present study was to investigate
the presence of functional P2X receptors in rat hepatocytes.2. Materials and methods
2.1. Materials
Williams’ medium E was obtained from Life Technology (Invitro-
gen, France), and collagenase A, from Boehringer (Roche Diagnostics,
France). P2X receptor primers for reverse transcriptase-polymerase
chain reaction (RT-PCR) and other chemicals were purchased from
Sigma (Sigma–Aldrich, France).
2.2. Hepatocyte preparation
Experiments were conducted according to EC directives for animal
experimentation (decree 2001-131; Oﬃcial Journal 06/02/01). Hepato-
cytes were prepared from fed Wistar rats as previously described [14].
Isolated rat hepatocytes were maintained (2 · 106 cells/mL) at room
temperature in Williams’ medium E supplemented with 10% fetal calf
serum, penicillin (200000 U/mL) and streptomycin (100 mg/mL). Cell
viability, assessed by trypan blue exclusion, remained >96%, for 4–5 h.
In some experiments, liposomal clodronate suspension (4 ml/kg) was
injected intravenously into the rats 48 h before inclusion in the exper-
iments, to eliminate Kupﬀer cells [15]. Monoclonal antibodies against
ED2 (Serotec, Oxford, UK), a marker of tissue macrophages [16], were
used in immunoﬂuorescence assays to assess the eﬀectiveness of liposo-
mal clodronate treatment (Supplementary Fig. 1S).
2.3. RT-PCR
Total RNA was extracted from freshly isolated hepatocytes, whole
heart and brain preparations, using Trireagent (Sigma), according
to the manufacturer’s recommendations. Reverse-transcribed mRNA
(cDNA) was ampliﬁed by PCR in the presence of independent sense
and antisense primers. Primers and PCR conditions are described in
the supplementary data (Table 1S). Ampliﬁcation products were sepa-
rated by gel electrophoresis (2% agarose) and visualised by ethidium
bromide staining.
2.4. Western blotting
Proteins (30–50 lg) in crude membrane preparations from hepato-
cytes were solubilised, resolved by 7.5% SDS–polyacrylamide gel elec-
trophoresis and transferred to a nitrocellulose membrane (Hybond
ECL, Amersham). The positive controls for P2X4 and P2X7 receptors
were, Respectively, rat salivary gland membranes [17] and c-myc
tagged mouse P2X7-transfected HEK cells lysates (kindly provided
by Dr. K. Benihoud). Immunoblotting was performed with anti-
P2X4 or anti-P2X7 polyclonal antibodies (Alomone) and the appropri-
ate peroxidase-conjugated secondary antibodies (Pierce). Peroxidase
activity was detected with an enhanced chemiluminescence kit (Amer-
sham Biosciences, Europe).blished by Elsevier B.V. All rights reserved.
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Fig. 1. Identiﬁcation of P2X receptor mRNA in isolated hepatocytes. Rat heart (P2X1, P2X4-5) and brain (P2X2-3, P2X6-7) preparations were used
as positive controls, and omission of reverse transcriptase from the reverse transcription mixture as a negative control (RT). P2X4 and P2X7
mRNAs were detected in each hepatocyte preparation (n = 6). The expected sizes of the DNA fragments are detailed in the supplementary data
(Table 1S).
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Isolated hepatocytes were seeded on glass slides, washed with PBS,
and ﬁxed (ethanol 30 min at 4 C, then acetone 1 min). Cells were incu-
bated for 1 h with the anti-P2X4 or anti-P2X7 antibody (1:200 in PBS),
then washed in PBS and incubated with the appropriate Alexa-conju-75 kDa
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Fig. 2. Expression of P2X4 and P2X7 receptors in isolated hepatocytes. (A)
mRNAs in hepatocytes isolated from control (lane 1) and clodronate-treated
P2X4 and P2X7 proteins in hepatocytes. For P2X4 detection (left panel), ra
hepatocyte lysates from control (lane 2) and clodronate-treated rats (lane 3). P
from control (lane 3) and clodronate-treated rats (lane 4). Lysates of P2X7-tr
not detected in wild-type HEK cells (lane 1). Results were conﬁrmed in at legated secondary antibodies (Molecular Probes). After mounting, cells
were examined with an Axioskop ﬂuorescence microscope (Zeiss, Ger-
many), or with a confocal microscope (Nikon EZC1) equipped with a
·63 plan-apochromatic oil immersion objective (NA = 1.4). Images
were processed using Image J software.1
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RT-PCR analysis showing similar levels of P2X4 and P2X7 receptor
rats (lane 2). (B) Western blot analysis demonstrating the presence of
t salivary gland membrane proteins (lane 1) were run in parallel with
2X7 (right panel) was detected at similar levels in hepatocytes isolated
ansfected HEK cells were used as a positive control (lane 2). P2X7 was
ast three independent experiments.
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Hepatocytes were plated onto glass coverslips coated with type I col-
lagen and loaded with 3 lMFura2-AM in modiﬁed Williams’ medium,
for 40 min, (37 C, 5% CO2). After washing the coverslips were trans-
ferred into a perfusion chamber placed on the stage of a Zeiss (Axio-
vert 35) inverted microscope. Calcium imaging was performed as
described previously [14]. Fluorescence images were collected by a
CCD camera (Princeton, USA), digitized and integrated in real time
by an image processor (Metaﬂuor, Princeton, USA).
2.7. YO-PRO-1 uptake
After isolation, hepatocytes were stored at room temperature in Ea-
gle medium supplemented with amino acids, vitamins and gelatin, and
gassed with O2/CO2 (19:1) at pH 7.4, until use, as described previously
[14]. Cells were centrifuged, washed and resuspended in 1 lM
4-[(3-methyl-2(3H)-benzoxazolylidene)methyl]-1-[3-(triethylammonio)
propyl]diiodide (YO-PRO-1) (Molecular Probes) in saline (mM: 116
NaCl, 5.4 KCl, 1.8 CaCl2, 0.8 MgCl2, 0.96 NaH2PO4, 5 NaHCO3,
20 HEPES, and 1 g/L glucose, pH 7.4). Cell suspensions were trans-
ferred either to a spectroﬂuorometer cuvette (5 · 105 cells/mL) and stir-
red with a magnetic bar at 37 C (Varian) or incubated for 30 min at
37 C in a 96-well ﬂat-bottomed microtiter plate (5 · 104 cells/well),
then ﬂuorescence was monitored in a 96-well plate ﬂuorometer (Victor
3, Wallac & Perkin–Elmer). In each case, ﬂuorescence was measured at
the optimum wavelengths for YO-PRO-1, 485 nm (kex) and 530 nm
(kem). Data were collected as arbitrary ﬂuorescence units, and increases
in ﬂuorescence induced by agents were expressed as a percentage of ba-
sal ﬂuorescence (DF/F%). In some experiments, Triton (0.01%) was
added to measure YO-PRO-1 maximum ﬂuorescence after cell perme-
abilization. Statistical analyses were performed with Prism version
4 (GraphPad Software, USA), using Student’s t-test, with P val-
ues < 0.05 considered signiﬁcant.Fig. 3. Immunolocalization of P2X4 and P2X7 receptors in isolated
hepatocytes. The distribution of the receptors was visualised using
FITC-conjugated secondary antibodies. Confocal microscopy: the
images correspond to a complete compiled z series of 22 xy sections
taken in 0.4 lm steps. (A) P2X4 was localised at the cell plasma
membrane and throughout the cytoplasm. Inset: Confocal analysis
showed strong labeling near the bile canaliculus area in hepatocyte
doublets. Compilation of 3z sections taken in 0.3 lm steps.
Bar = 10 lm. (B) Staining with the anti-P2X7 antibody was patchy
and restricted to the plasma membrane. Inset: no staining for the P2X7
receptor was detected in the bile canaliculus area. Compilation of 3 z
sections taken in 0.3 lm steps. Bar = 10 lm.3. Results and discussion
3.1. Detection of P2X receptor subunits in hepatocytes
cDNAs generated from six independent rat hepatocyte prep-
arations were probed by RT-PCR, using pairs of oligonucleo-
tides speciﬁc for P2X1–7 ampliﬁcation. As a positive control,
ampliﬁed products of the appropriate sizes for P2X1, P2X4
and P2X5 were detected following PCR with rat heart cDNA
and products corresponding to P2X2, P2X3, P2X6 and P2X7
were detected following PCR with rat brain cDNA [18].
P2X4, and P2X7 mRNAs were present in all hepatocyte prep-
arations (Fig. 1) in which we did not detect mRNAs for P2X1,
P2X2, P2X3, and P2X5. P2X6 mRNA gave a weak signal in
one preparation.
P2X4 and P2X7 receptors are expressed at high levels in
macrophages [1,19]. The resident liver macrophages, Kupﬀer
cells, have recently been shown to express P2X4 and P2X6
receptors [20]. Although the method of hepatocyte isolation
used in this study yielded a cellular population containing
99% hepatocytes [21], possible contamination with Kupﬀer
cells has to be considered. We, therefore, isolated hepatocytes
from rats treated with clodronate liposomes, which selectively
eliminates macrophages (Supplementary Fig. 1S) and found
that P2X4, and P2X7 mRNAs were similarly detected in con-
trol and treated rats (Fig. 2A).
3.2. Identiﬁcation of P2X4 and P2X7 receptor proteins in
hepatocytes
We found both P2X4 and P2X7 receptor proteins in hepato-
cytes isolated from control or clodronate-treated rats by Wes-
tern blot analysis with isoform-speciﬁc antibodies (Fig. 2B). As
shown in other cell types [22], although the predicted molecu-
lar mass of P2X4 is about 46 kDa, protein bands of 65 kDawere recognised for P2X4 both in rat salivary gland mem-
branes and in hepatocyte membranes isolated from the livers
of control or clodronate-treated rats. For Western blot analy-
sis of P2X7 expression, hepatocyte lysates from the livers of
control or clodronate-treated rats were run in parallel with
sample lysates from wild-type or c-myc tagged mouse P2X7
HEK transfected cells. As in other cell types [23], the antibody
recognised a distinct protein band at 70 kDa. The protein de-
tected in transfected HEK cells lysates was slightly larger than
the rat P2X7 receptor, due to both the presence of a c-myc tag
and interspecies diﬀerence [18]. In each case, immunoreactivity
was prevented by prior incubation of the antibody with its cog-
nate peptide (data not shown).
The molecular mass of about 70 kDa for each receptor sub-
unit is consistent with published data describing P2X receptors
E. Gonzales et al. / FEBS Letters 581 (2007) 3260–3266 3263as highly glycosylated proteins[18]. The presence of alterna-
tively spliced P2X receptor isoforms, together with post-trans-
lational modiﬁcations, gives rise to potentially large variations
in the size of the detected proteins [18,24].
3.3. Immunolocalization of P2X4 and P2X7 in hepatocytes
We next investigated the distribution of P2X4 and P2X7
immunoreactivity in isolated hepatocytes. Staining with anti-
P2X4 antibody was patchy, and located both at the plasma
membrane and throughout the cytoplasm (Fig. 3A and Sup-
plementary Movie 1S). Interestingly, in almost all the hepato-
cyte doublets analyzed, strong labeling was observed near the
bile canaliculus area (Fig. 3A inset). This particular distribu-
tion is consistent with the already reported role of P2X4 recep-
tor in bile secretion [25]. In contrast, anti-P2X7 staining was
not preferentially localized in the area of the bile canaliculus.Bz-ATP (30 µM)
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3.4. Functionality of P2X receptors in hepatocytes
If ATP is added onto cells for a short time, the P2X4 and
P2X7 receptors operate as cation-selective channels [18]. This
is particularly true for P2X4, which has a relatively high Ca2+
permeability. However, assessments of the increase in Ca2+
concentration in hepatocytes for evaluations of the functional-
ity of P2X receptors may be complicated by the presence of G
protein-coupled P2Y receptors, which induce an increase in
Ca2+ concentration through an inositol 1,4,5-trisphosphate
(InsP3) production [10]. In eﬀect, as shown in Fig. 4, addition
of low concentration of 2 0-and 3 0-O-(4-benzoylbenzoyl)-ATP
(BzATP; 30 lM), the P2X-preferring agonist, induced Ca2+
oscillations similar to those induced by InsP3 dependentBz-ATP (300 µM)
2
3
4
5
4 5
cell a
cell c
cell b
Bz-ATP (300 µM)
ocytes. (A) fura-2-loaded hepatocytes were sequentially stimulated with
y the horizontal bars. Addition of the low dose of BzATP was followed
of a high concentration of BzATP (300 lM) induced a rapid and strong
ond large Ca2+ increase and a release of fura2 (cell a and c in images 3
ot modify the BzATP-induced Ca2+ increase but completely prevented
own are representative of the Ca2+ signal observed in the presence of
0 10 20 30 40 50 60
0
50
100
150
200
250
0
50
100
150
200
250
Time, min
Fl
uo
re
sc
en
ce
, A
U
BzATP (300 µM) Triton
0 10 100 1000
0
25
50
75
100
125
150
175
ΔF
/F
0 
(%
)
BzATP
oATP + BzATP
oATP
control
BzATP BzATP
+ oATP
ΔF
/F
 (%
)
100
140
180
220
*
Agonist [µM]
Fig. 5. YO-PRO-1 uptake in hepatocytes. (A) Time-course of YO-
PRO-1 uptake in isolated hepatocytes, determined as the increase in
ﬂuorescence over time. Hepatocytes were incubated in the presence or
absence of oATP (300 lM) for 2 h at 37 C. Cells were transferred in
spectroﬂuorometer cuvettes and YO-PRO-1 (1 lM) was added onto
cells at t = 0. BzATP (300 lM) or vehicle was added 3 min later
(arrow). Triton (T, 0.01%) was added at the end of the experiments to
assess the YO-PRO-1 maximum ﬂuorescence after cell permeabiliza-
tion. Traces are representative of ﬁve independent experiments. (B)
Dose–response curves for BzATP and ATP-induced YO-PRO-1
uptake. Suspensions of hepatocytes were added to 96-well plates
(50000 cells/well) and incubated for 30 min at 37 C with YO-PRO-1
(1 lM) and BzATP (n) or ATP (.). Changes in YO-PRO-1 ﬂuores-
cence were then monitored in a 96-well plate ﬂuorometer. Values were
normalized with respect to the ﬂuorescence measured in cells incubated
for the same time in the presence of YO-PRO-1 alone for each
experiment (% of control cells). Inset: Preincubation with oATP
(300 lM, 2 h) signiﬁcantly reduced the uptake of YO-PRO-1 induced
by BzATP (300 lM). The data are means ± S.E.M. for four to eight
determinations in three independent experiments.
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were not signiﬁcantly modiﬁed by prior incubation of hepato-
cytes for 2 h with oxidised ATP (oATP) (300 lM), an antago-
nist with some speciﬁcity for the P2X7 receptor [11,18,26]
(Fig. 4B). In the same way, as with InsP3 dependent agonists,
an increase in the concentration of BzATP (300 lM) induced
a sustained Ca2+ increase. However, it is particularly interesting
to note that BzATP at this concentration, in contrast with other
agonists, causes a large calcium increase which is followed very
quickly by a release of fura2 in some cells (Fig. 4). These eﬀects
were completely prevented when hepatocytes were pre-incu-
bated for 2 h with oATP (300 lM) (Fig. 4B). These observa-
tions, in particular the leak of fura2, suggest that P2X7, and
possibly P2X4 receptors, could be functional in hepatocytes.
Indeed, it is well known that these receptors, particulary
P2X7, are able to form a non-selective membrane pore perme-
able to solutes with molecular masses up to about 800 Da [18].
Consequently, we examined the cells for permeability to YO-
PRO-1 in the presence of ATP or BzATP.
A typical YO-PRO-1 uptake experiment carried out in spec-
troﬂuorometer cuvettes is shown in Fig. 5A. A time-dependent
increase in ﬂuorescence intensity was observed in hepatocytes
upon BzATP challenge. The increase in YO-PRO-1 accumula-
tion was detected within 10 min of agonist application and stea-
dy state was reached approximately 30 min after the addition of
BzATP (Fig. 5A). The dose–response curve obtained after incu-
bation with BzATP for 30 min showed an EC50 around 450 lM
(Fig. 5B). Furthermore, BzATP-stimulated dye uptake was sig-
niﬁcantly inhibited by the prior incubation of hepatocytes for
2 h with oATP (300 lM) (Fig. 5B inset). Oxidised ATP did
not completely inhibit the YO-PRO-1 uptake induced by
BzATP, suggesting that, under these conditions, P2X4 also
formed a non-selective membrane pore in hepatocytes, as
shown in other cell types [18]. The addition of a very high con-
centration of ATP (1 mM) gave similar results (Fig. 5B and
data not shown). This pharmacological behavior is consistent
with the agonist proﬁle of P2X7, with BzATP being more po-
tent than ATP for activation of this receptor [18].
A unique feature that distinguishes P2X7 receptors from
other P2X receptors is their ability to induce changes in cell
morphology, cytoskeletal architecture and membrane blebbing
[18,27,28]. Incubation of hepatocytes with BzATP (100 lM) or
ATP (1 mM) for 15 min triggered membrane blebbing in about
50% of the cells (110/218 cells), (n = 3), (Fig. 6). This percent-
age increased markedly to about 90% (229/256 cells) when
hepatocytes were incubated with 300 lM BzATP, whereas
prior incubation with oATP (300 lM) for 2 h almost com-
pletely prevented blebbing (12/255 cells). Perfusion of BzATP
(300 lM) or ATP (1 mM) for a short period of time (2–
3 min) induced membrane blebs, which appeared rapidly in
some hepatocytes, and much more slowly in others (Fig. 6B,
and Supplementary Mov. 2S). Membrane blebs were fully
reversible in almost all hepatocytes (Supplementary Mov.
2S). YO-PRO-1 uptake was also observed over the same time
frame, did not correlate with membrane blebbing. As reported
for other cell types [18,27], blebs could appear before or after
the detection of YO-PRO-1 ﬂuorescence (Fig. 6).
YO-PRO-1 uptake and membrane blebbing, both of which
induced by BzATP and ATP and inhibited by oATP, indicated
that P2X7 receptors, and possibly P2X4 receptors, were func-
tional. These two receptors are commonly expressed in the
same tissues or cells [1]. However, in our condition, it is verydiﬃcult to distinguish the activation of P2X4 from that of
P2X7 [18,25]. Moreover, P2Y receptor expression by hepato-
cytes complicates the issue even further [10]. Nevertheless,
BzATP and high concentrations of ATP induced membrane
blebbing, strongly suggests that P2X7 receptors are functional,
as this eﬀect is associated with the activation of P2X7 receptors
only [18,27,28]. The expression of functional P2X7 receptors in
hepatocytes could account for the observation that submillim-
olar concentrations of extracellular ATP induces the death of
these cells [12,29] and open up new ﬁelds of investigation, as
this receptor has speciﬁc properties including cytotoxicity
and a role in apoptosis induction.
Fig. 6. BzATP and ATP induced the formation of membrane blebs in isolated hepatocytes. Formation of membrane blebs induced by BzATP
(300 lM, panel A) or ATP (1 mM, panel B), monitored by phase contrast microscopy (left columns). The right columns show YO-PRO-1 uptake for
the same cells, as assessed by epiﬂuorescence microscopy. Images were taken at T = 0 and 5 and 15 min after the addition of agonists.
E. Gonzales et al. / FEBS Letters 581 (2007) 3260–3266 3265Including our results, at least ﬁve P2 receptors (P2Y1, P2Y2,
P2Y4, P2X4 and P2X7) have been identiﬁed in hepatocytes.
Each of these receptors can increase intracellular Ca2+ concen-
tration. Potentially located in diﬀerent parts of the cell, these
receptors would allow ﬁne modulation of the Ca2+ signal in
time and space which might account for the involvement of
ATP in many diﬀerent situations, such as regulation of cell vol-
ume [5], resistance to hypoxia [30], bile secretion [25] and liver
regeneration [31].
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